Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.

Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 2015 Nov; 53(5):585-600.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.